Melanoma-Pancreatic Cancer Syndrome, also known as familial atypical multiple mole melanoma-pancreatic carcinoma syndrome, is related to melanoma and melanoma, cutaneous malignant 1. An important gene associated with Melanoma-Pancreatic Cancer Syndrome is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A). Affiliated tissues include breast and skin, and related phenotypes are melanoma and sarcoma